New IBD insights; Adding antiangiogenesis drugs amps up efficacy of radiation therapy;

> Scientists at Beth Israel Deaconess Medical Center have been studying the role an immunosuppressive pathway plays in IBD. Release

> A team at Massachusetts General Hospital says that adding antiangiogenesis drugs may "improve the effectiveness of radiation treatment of nervous system tumors that interfere with the hearing of patients with the genetic disorder neurofibromatosis 2." Release

Suggested Articles

Dutch scientists used stem cells from CF patients to demonstrate a technique that corrects a mutation in the gene CFTR without having to cut DNA.

A new map of the thymus gland could help researchers understand how T cells develop and inspire treatments for cancer and autoimmune disease.

Brigham and Women’s Hospital scientists linked a noncoding RNA to atherosclerosis in a discovery that could aid in the development of new heart drugs.